Literature DB >> 29463433

Carbon-ion radiotherapy for locoregional recurrence after primary surgery for pancreatic cancer.

Shohei Kawashiro1, Shigeru Yamada2, Yuka Isozaki2, Kenji Nemoto3, Hiroshi Tsuji2, Tadashi Kamada2.   

Abstract

The efficacy and safety of carbon ion radiotherapy (C-ion RT) for locoregional recurrence after surgery for pancreatic cancer were retrospectively evaluated. The results for 30 patients showed that C-ion RT was performed safely with relatively long overall survival, good local control, and minimal toxicity.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbon-ion radiotherapy; Locoregional recurrence; Pancreatic cancer; Postoperative; Prognostic factor

Mesh：

Year:  2018        PMID： 29463433     DOI： 10.1016/j.radonc.2018.02.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  8 in total

1.  Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy.

Authors:  Yasuhito Hagiwara; Shigeru Yamada; Yuka Isozaki; Hirotoshi Takiyama; Makoto Shinoto; Shohei Kawashiro; Tapesh Bhattacharyya; Kenji Nemoto; Hiroshi Tsuji
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-06

2.  Evaluation of Intensity- and Contour-Based Deformable Image Registration Accuracy in Pancreatic Cancer Patients.

Authors:  Yoshiki Kubota; Masahiko Okamoto; Yang Li; Shintaro Shiba; Shohei Okazaki; Shuichiro Komatsu; Makoto Sakai; Nobuteru Kubo; Tatsuya Ohno; Takashi Nakano
Journal:  Cancers (Basel)       Date:  2019-09-27       Impact factor: 6.639

3.  A clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy.

Authors:  Kumiko Karasawa; Tokuhiko Omatsu; Shintaro Shiba; Daisuke Irie; Masaru Wakatsuki; Shigekazu Fukuda
Journal:  Radiat Oncol       Date:  2020-11-13       Impact factor: 3.481

4.  Carbon-Ion Beam Irradiation and the miR-200c Mimic Effectively Eradicate Pancreatic Cancer Stem Cells Under in vitro and in vivo Conditions.

Authors:  Sei Sai; Eun Ho Kim; Woong Sub Koom; Guillaume Vares; Masao Suzuki; Shigeru Yamada; Mitsuhiro Hayashi
Journal:  Onco Targets Ther       Date:  2021-09-16       Impact factor: 4.147

5.  Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study.

Authors:  Jakob Liermann; Patrick Naumann; Adriane Hommertgen; Moritz Pohl; Meinhard Kieser; Juergen Debus; Klaus Herfarth
Journal:  BMC Cancer       Date:  2020-10-01       Impact factor: 4.430

6.  Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United States.

Authors:  Timothy D Malouff; Laura A Vallow; Danushka Seneviratne; Anita Mahajan; Robert L Foote; Bradford Hoppe; Chris Beltran; Steven J Buskirk; Sunil Krishnan; Daniel M Trifiletti
Journal:  Int J Part Ther       Date:  2020-11-05

Review 7.  Who Will Benefit from Charged-Particle Therapy?

Authors:  Kyung Su Kim; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2021-06-21       Impact factor: 4.679

8.  Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer.

Authors:  Jakob Liermann; Edgar Ben-Josef; Mustafa Syed; Juergen Debus; Klaus Herfarth; Patrick Naumann
Journal:  Strahlenther Onkol       Date:  2021-08-05       Impact factor: 3.621
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.